Results 141 to 150 of about 34,737 (245)
The Inhibitory Effects of Zinc Oxide Nanoparticles on Clinical Isolates of Malassezia in Dogs
Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.Zinc oxide nanoparticles inhibit the growth and virulence of Malassezia pachydermatis clinical isolates from dogs. ZnO NPs exhibit potent fungicidal activity at low concentrations (MIC 3.90–7.81 ppm) and significantly downregulate the expression of Phospholipase A2 and Aspartyl proteinase genes, key virulence factors. This demonstrates the potential of
Alaleh Vazifehdust +5 more
wiley +1 more source
IET Nanobiotechnology, Volume 2026, Issue 1, 2026.The stem rust disease caused by obligate biotrophic fungus Puccinia graminis f. sp. tritici is a worldwide threat to the global wheat production with frequent epidemics leading to widespread reliance on chemical fungicides such as cyproconazole. To reduce fungicide risks on human health and environmental integrity, chitosan nanoparticles (CNPs) and ...
Jafar Fathi-Qarachal +4 more
wiley +1 more source
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025
HIV Medicine, Volume 27, Issue 1, Page 18-32, January 2026.Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni +19 more
wiley +1 more source
Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page 29-45, January 2026.There is a concerning trend of widespread and severe superficial fungal infections caused by a new pathogen—Trichophyton indotineae—resistant to standard antifungal therapies. T. indotineae is now spreading globally and evolving. There is increasing urgency for healthcare providers and policy makers to initiate surveillance systems and antifungal ...
Aditya K. Gupta +11 more
wiley +1 more source
Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. [PDF]
, 1994 Anonymous +18 more
core +1 more source
Mycoses, Volume 69, Issue 1, January 2026.ABSTRACT Background Typing Aspergillus species is crucial for understanding the sources of infection in hospital environments. Objectives This study analysed clinical and air samples as well as their relationship with the clinical forms of aspergillosis.
Claudia de Abreu Fonseca +18 more
wiley +1 more source
Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts
Mycoses, Volume 69, Issue 1, January 2026.ABSTRACT The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve ...
A. Apostolopoulou +7 more
wiley +1 more source
Mycoses, Volume 69, Issue 1, January 2026.ABSTRACT Background Invasive fungal infections (IFI) are a prominent cause of morbidity and mortality among patients with haematological malignancies (HMs). Diagnostic work‐up excluding IFI is mandatory in case of persistent fever while antifungal treatment (AFT) is started.
Criscuolo Marianna +29 more
wiley +1 more source
Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real‐World Setting
Mycoses, Volume 69, Issue 1, January 2026.ABSTRACT Background Since rifabutin has less severe drug interactions, it is preferred over rifampin when administered concomitantly with azole antifungals. However, limited data exist to evaluate this interaction. Methods This was a single‐centre study of hospitalised patients who received concomitant isavuconazole and rifabutin prior to plasma ...
Sunish Shah +6 more
wiley +1 more source
Overcoming resistance of Candida albicans using photodynamic inactivation
Photochemistry and Photobiology, Volume 102, Issue 1, Page 127-140, January/February 2026.The rising resistance of Candida albicans to conventional antifungals, like Amphotericin B (AmB), highlights the need for alternative treatments. This study evaluated the antifungal effectiveness of combining AmB with photodynamic inactivation (PDI) using curcumin as a photosensitizer.
Gabriela Gomes Guimarães +5 more
wiley +1 more source